These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 30261266)
41. 'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanid. Köser CU; Maurer FP; Kranzer K Int J Infect Dis; 2019 Mar; 80S():S32-S35. PubMed ID: 30818049 [TBL] [Abstract][Full Text] [Related]
42. atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure. Le Ray LF; Aubry A; Sougakoff W; Revest M; Robert J; Bonnet I; Veziris N; Morel F Emerg Infect Dis; 2022 May; 28(5):1062-1064. PubMed ID: 35447056 [TBL] [Abstract][Full Text] [Related]
44. Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains. Battaglia S; Spitaleri A; Cabibbe AM; Meehan CJ; Utpatel C; Ismail N; Tahseen S; Skrahina A; Alikhanova N; Mostofa Kamal SM; Barbova A; Niemann S; Groenheit R; Dean AS; Zignol M; Rigouts L; Cirillo DM J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907992 [TBL] [Abstract][Full Text] [Related]
45. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. Ferlazzo G; Mohr E; Laxmeshwar C; Hewison C; Hughes J; Jonckheere S; Khachatryan N; De Avezedo V; Egazaryan L; Shroufi A; Kalon S; Cox H; Furin J; Isaakidis P Lancet Infect Dis; 2018 May; 18(5):536-544. PubMed ID: 29452942 [TBL] [Abstract][Full Text] [Related]
46. Global Introduction of New Multidrug-Resistant Tuberculosis Drugs-Balancing Regulation with Urgent Patient Needs. Sullivan T; Ben Amor Y Emerg Infect Dis; 2016 Mar; 22(3):. PubMed ID: 26889711 [TBL] [Abstract][Full Text] [Related]
47. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants. Ismail N; Omar SV; Ismail NA; Peters RPH J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087 [TBL] [Abstract][Full Text] [Related]
48. Antibiotic resistance mechanisms in M. tuberculosis: an update. Nguyen L Arch Toxicol; 2016 Jul; 90(7):1585-604. PubMed ID: 27161440 [TBL] [Abstract][Full Text] [Related]
49. New Drugs for the Treatment of Tuberculosis. Ignatius EH; Dooley KE Clin Chest Med; 2019 Dec; 40(4):811-827. PubMed ID: 31731986 [TBL] [Abstract][Full Text] [Related]
50. Comparison of Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043 [TBL] [Abstract][Full Text] [Related]
51. Fitness of acquired drug resistant Mycobacterium tuberculosis isolates from DOTS compliant patients. Bhatter P; Mistry N Tuberculosis (Edinb); 2013 Jul; 93(4):418-24. PubMed ID: 23615069 [TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany. Wirth D; Dass R; Hettle R BMC Health Serv Res; 2017 Mar; 17(1):182. PubMed ID: 28270207 [TBL] [Abstract][Full Text] [Related]
53. Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola. Rando-Segura A; Aznar ML; Moreno MM; Espasa M; Sulleiro E; Bocanegra C; Gil E; Eugénio ANE; Escartin C; Zacarias A; Vegue J; Katimba D; Vivas MC; Gabriel E; Marina MC; Mendioroz J; López MT; Pumarola T; Molina I; Tórtola MT Emerg Infect Dis; 2018 Mar; 24(3):569-572. PubMed ID: 29460748 [TBL] [Abstract][Full Text] [Related]
54. Adduct Formation of Delamanid with NAD in Mycobacteria. Hayashi M; Nishiyama A; Kitamoto R; Tateishi Y; Osada-Oka M; Nishiuchi Y; Kaboso SA; Chen X; Fujiwara M; Inoue Y; Kawano Y; Kawasaki M; Abe T; Sato T; Kaneko K; Itoh K; Matsumoto S; Matsumoto M Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152081 [TBL] [Abstract][Full Text] [Related]
55. Detection of resistance to anti-tuberculosis drugs in the clinical isolates of Mycobacterium tuberculosis from Slovakia through comparison between phenotypic and genetic methods and evaluation of resistance levels with clinical parameter. Mokry J; Porvaznik I; Kusnir P; Dohal M; Solovic I J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31172969 [TBL] [Abstract][Full Text] [Related]
56. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis. Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727 [TBL] [Abstract][Full Text] [Related]